Literature DB >> 19576893

Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation.

Insun Song1, Jung Ha Kim, Kabsun Kim, Hye Mi Jin, Bang Ung Youn, Nacksung Kim.   

Abstract

NFATc1 is a master regulator of RANKL-induced osteoclast differentiation and herein we investigate the regulatory mechanism of NFATc1 in osteoclast activation. Inactivation of NFATc1 strongly attenuates RANKL-induced bone resorption and overexpression of a constitutively active form of NFATc1 in osteoclasts induces formation of actin rings and resorption pits on dentin slices. We demonstrate that NFATc1 binds directly to the promoter regions of its target genes and induces expression of various genes, including LTBP3, ClC7, cathepsin K, MMP9, and c-Src, which are key players in bone resorption. Thus, NFATc1 is essential for RANKL-induced osteoclast activation via up-regulation of osteoclast-activating genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19576893     DOI: 10.1016/j.febslet.2009.06.047

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  48 in total

1.  Stage-specific functions of leukemia/lymphoma-related factor (LRF) in the transcriptional control of osteoclast development.

Authors:  Kaori Tsuji-Takechi; Takako Negishi-Koga; Eriko Sumiya; Akiko Kukita; Shigeaki Kato; Takahiro Maeda; Pier Paolo Pandolfi; Keiji Moriyama; Hiroshi Takayanagi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Interleukin-4 inhibits RANKL-induced NFATc1 expression via STAT6: a novel mechanism mediating its blockade of osteoclastogenesis.

Authors:  Jing Cheng; Jianzhong Liu; Zhenqi Shi; Duorong Xu; Shaokai Luo; Gene P Siegal; Xu Feng; Shi Wei
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

3.  Response of a preosteoblastic cell line to cyclic tensile stress conditioning and growth factors for bone tissue engineering.

Authors:  Eunna Chung; Marissa Nichole Rylander
Journal:  Tissue Eng Part A       Date:  2011-11-08       Impact factor: 3.845

4.  Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss.

Authors:  X Yuan; J Cao; T Liu; Y-P Li; F Scannapieco; X He; M J Oursler; X Zhang; J Vacher; C Li; D Olson; S Yang
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

5.  Adipocytes enhance expression of osteoclast adhesion-related molecules through the CXCL12/CXCR4 signalling pathway.

Authors:  Tingting Luo; Hongrui Liu; Wei Feng; Di Liu; Juan Du; Jing Sun; Wei Wang; Xiuchun Han; Jie Guo; Norio Amizuka; Xianqi Li; Minqi Li
Journal:  Cell Prolif       Date:  2016-11-21       Impact factor: 6.831

6.  Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways.

Authors:  Megan M Weivoda; Ming Ruan; Christine M Hachfeld; Larry Pederson; Alan Howe; Rachel A Davey; Jeffrey D Zajac; Yasuhiro Kobayashi; Bart O Williams; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  J Bone Miner Res       Date:  2015-08-19       Impact factor: 6.741

7.  E proteins regulate osteoclast maturation and survival.

Authors:  Courtney L Long; William L Berry; Ying Zhao; Xiao-Hong Sun; Mary Beth Humphrey
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741

8.  Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression.

Authors:  Xiang-zhou Zeng; Long-gang He; Song Wang; Keng Wang; Yue-yang Zhang; Lei Tao; Xiao-juan Li; Shu-wen Liu
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

9.  Genistein attenuates glucocorticoid-induced bone deleterious effects through regulation Eph/ephrin expression in aged mice.

Authors:  Yuan Cheng; Wei-Lin Wang; Jun-Jun Liang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

10.  Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts.

Authors:  Yukiko Kuroda; Koichi Matsuo
Journal:  World J Orthop       Date:  2012-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.